Development
ADMA Biologics, Inc.
ADMA
$18.96
-$0.95-4.77%
NASDAQ
| 12/31/2023 | 09/30/2023 | 06/30/2023 | 03/31/2023 | 12/31/2022 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 51.35M | 74.16M | 62.51M | 69.20M | 86.52M |
| Total Receivables | 27.42M | 31.32M | 36.73M | 26.52M | 15.51M |
| Inventory | 172.91M | 163.12M | 161.78M | 163.98M | 163.28M |
| Prepaid Expenses | 5.33M | 5.11M | 5.22M | 4.38M | 5.10M |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 257.01M | 273.70M | 266.24M | 264.09M | 270.40M |
|
|
|||||
| Total Current Assets | 257.01M | 273.70M | 266.24M | 264.09M | 270.40M |
| Net Property, Plant & Equipment | 63.47M | 64.57M | 66.31M | 67.62M | 68.75M |
| Long-term Investments | 3.53M | 3.53M | 3.53M | 3.53M | 3.53M |
| Goodwill | 3.53M | 3.53M | 3.53M | 3.53M | 3.53M |
| Total Other Intangibles | 499.00K | 476.90K | 655.70K | 834.60K | 1.01M |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 4.67M | 6.72M | 6.29M | 4.72M | 4.77M |
| Total Assets | 329.18M | 349.00M | 343.03M | 340.79M | 348.46M |
|
|
|||||
| Total Accounts Payable | 15.66M | 10.85M | 12.08M | 12.96M | 13.23M |
| Total Accrued Expenses | 30.01M | 27.25M | 26.55M | 20.63M | 23.19M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 1.05M | 982.90K | 979.50K | 956.00K | 905.00K |
| Total Finance Division Other Current Liabilities | 3.09M | 2.76M | 2.34M | 2.18M | 1.94M |
| Total Other Current Liabilities | 3.09M | 2.76M | 2.34M | 2.18M | 1.94M |
| Total Current Liabilities | 49.81M | 41.84M | 41.95M | 36.73M | 39.27M |
|
|
|||||
| Total Current Liabilities | 49.81M | 41.84M | 41.95M | 36.73M | 39.27M |
| Long-Term Debt | 130.59M | 142.03M | 140.31M | 144.30M | 142.83M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 9.78M | 9.97M | 10.22M | 10.47M | 10.70M |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 3.80M | 3.73M | 3.78M | 3.64M | 3.68M |
| Total Liabilities | 193.98M | 197.56M | 196.26M | 195.13M | 196.49M |
|
|
|||||
| Common Stock & APIC | 641.46M | 640.05M | 637.94M | 630.46M | 629.99M |
| Retained Earnings | -506.26M | -488.61M | -491.18M | -484.81M | -478.02M |
| Treasury Stock & Other | -- | -- | -- | -- | -- |
| Total Common Equity | 135.21M | 151.44M | 146.76M | 145.65M | 151.97M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 135.21M | 151.44M | 146.76M | 145.65M | 151.97M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 135.21M | 151.44M | 146.76M | 145.65M | 151.97M |
|
|
|||||